unknown
Stage
2025
Founded
4
Investors
About
Cellanome is a biotechnology company developing a novel single-cell multi-omics platform. Their technology integrates genomics, transcriptomics, and proteomics at the single-cell level to accelerate drug discovery and development.
Explore Cellanome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.